News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
475,144 Results
Type
Article (22670)
Company Profile (78)
Press Release (452392)
Multimedia
Podcasts (25)
Webinars (9)
Section
Business (137114)
Career Advice (1348)
Deals (27341)
Drug Delivery (66)
Drug Development (53261)
Employer Resources (121)
FDA (10720)
Job Trends (10301)
News (232652)
Policy (22566)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1672)
Accelerated approval (26)
Adcomms (31)
Allergies (83)
Alliances (31626)
ALS (118)
Alzheimer's disease (1199)
Antibody-drug conjugate (ADC) (203)
Approvals (10910)
Artificial intelligence (319)
Autoimmune disease (99)
Automation (23)
Bankruptcy (223)
Best Places to Work (8594)
BIOSECURE Act (8)
Biosimilars (115)
Biotechnology (59)
Bladder cancer (135)
Brain cancer (38)
Breast cancer (517)
Cancer (3641)
Cardiovascular disease (298)
Career advice (1146)
Career pathing (18)
CAR-T (197)
CDC (41)
Celiac Disease (1)
Cell therapy (496)
Cervical cancer (27)
Clinical research (46177)
Collaboration (1103)
Company closure (1)
Compensation (508)
Complete response letters (40)
COVID-19 (1909)
CRISPR (50)
C-suite (603)
Cystic fibrosis (123)
Data (4787)
Denatured (8)
Depression (94)
Diabetes (350)
Diagnostics (4867)
Digital health (20)
Diversity (6)
Diversity, equity & inclusion (30)
Drug discovery (151)
Drug pricing (126)
Drug shortages (20)
Duchenne muscular dystrophy (173)
Earnings (61987)
Editorial (42)
Employer branding (17)
Employer resources (109)
Events (72452)
Executive appointments (730)
FDA (13056)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (8)
Frontotemporal dementia (17)
Funding (920)
Gene editing (111)
Generative AI (25)
Gene therapy (385)
GLP-1 (596)
Government (3759)
Grass and pollen (4)
Guidances (360)
Healthcare (13330)
HIV (38)
Huntington's disease (32)
IgA nephropathy (58)
Immunology and inflammation (150)
Immuno-oncology (39)
Indications (86)
Infectious disease (2112)
Inflammatory bowel disease (121)
Inflation Reduction Act (7)
Influenza (82)
Intellectual property (146)
Interviews (176)
IPO (14455)
IRA (26)
Job creations (2046)
Job search strategy (992)
JPM (28)
Kidney cancer (14)
Labor market (41)
Layoffs (293)
Leadership (20)
Legal (5108)
Liver cancer (61)
Longevity (12)
Lung cancer (479)
Lymphoma (301)
Machine learning (22)
Management (46)
Manufacturing (431)
MASH (127)
Medical device (9554)
Medtech (9591)
Mergers & acquisitions (13809)
Metabolic disorders (829)
Multiple sclerosis (110)
NASH (15)
Neurodegenerative disease (217)
Neuropsychiatric disorders (63)
Neuroscience (2062)
Neurotech (1)
NextGen: Class of 2026 (4193)
Non-profit (3247)
Now hiring (16)
Obesity (344)
Opinion (199)
Ovarian cancer (133)
Pain (136)
Pancreatic cancer (172)
Parkinson's disease (193)
Partnered (26)
Patents (302)
Patient recruitment (309)
Peanut (34)
People (41990)
Pharmaceutical (24)
Pharmacy benefit managers (32)
Phase 1 (13395)
Phase 2 (20216)
Phase 3 (16355)
Pipeline (4093)
Policy (193)
Postmarket research (1687)
Preclinical (5768)
Press Release (69)
Prostate cancer (185)
Psychedelics (34)
Radiopharmaceuticals (200)
Rare diseases (616)
Real estate (3293)
Recruiting (49)
Regulatory (16940)
Reports (29)
Research institute (1459)
Resumes & cover letters (217)
Rett syndrome (23)
RNA editing (8)
RSV (54)
Schizophrenia (114)
Series A (123)
Series B (108)
Service/supplier (3)
Sickle cell disease (63)
Special edition (14)
Spinal muscular atrophy (121)
Sponsored (20)
Startups (2131)
State (1)
Stomach cancer (11)
Supply chain (58)
Tariffs (41)
The Weekly (16)
Vaccines (661)
Venture capital (52)
Weight loss (209)
Women's health (48)
Worklife (12)
Date
Today (8)
Last 7 days (412)
Last 30 days (1588)
Last 365 days (21628)
2026 (2012)
2025 (21887)
2024 (25392)
2023 (29157)
2022 (37806)
2021 (41012)
2020 (39512)
2019 (32544)
2018 (24568)
2017 (22274)
2016 (20575)
2015 (25049)
2014 (18753)
2013 (15043)
2012 (15942)
2011 (16479)
2010 (15209)
Location
Africa (527)
Alabama (65)
Alaska (6)
Arizona (164)
Arkansas (8)
Asia (25992)
Australia (4256)
California (7975)
Canada (2702)
China (740)
Colorado (330)
Connecticut (358)
Delaware (240)
Europe (60977)
Florida (1143)
Georgia (229)
Hawaii (1)
Idaho (36)
Illinois (561)
India (46)
Indiana (344)
Iowa (15)
Japan (338)
Kansas (93)
Kentucky (25)
Louisiana (21)
Maine (65)
Maryland (967)
Massachusetts (5563)
Michigan (191)
Minnesota (408)
Mississippi (5)
Missouri (108)
Montana (27)
Nebraska (20)
Nevada (100)
New Hampshire (65)
New Jersey (2314)
New Mexico (11)
New York (2181)
North Carolina (976)
North Dakota (6)
Northern California (3971)
Ohio (216)
Oklahoma (14)
Oregon (22)
Pennsylvania (1590)
Puerto Rico (12)
Rhode Island (38)
South America (700)
South Carolina (51)
South Dakota (1)
Southern California (3049)
Tennessee (123)
Texas (1229)
United States (28124)
Utah (216)
Vermont (1)
Virginia (195)
Washington D.C. (61)
Washington State (697)
West Virginia (3)
Wisconsin (89)
Wyoming (2)
475,144 Results for "maps public benefit corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
January 21, 2026
·
7 min read
Press Releases
Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia
February 4, 2026
·
11 min read
Press Releases
Anteris Technologies Global Corp. Announces Closing of $230 Million Public Offering of Common Stock
January 23, 2026
·
6 min read
Vaccines
ACIP Chair Questions Polio Vaccines, Values Individual Choice Over Public Benefit
“I don’t like established science,” ACIP chairperson Kirk Milhoan said in an interview on the Why Should I Trust You? podcast. “Science is what I observe.”
January 23, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Anteris Technologies Global Corp. Announces Proposed $200 Million Public Offering of Common Stock and Strategic Investment from Medtronic
January 21, 2026
·
6 min read
Biotech Bay
MAPS Public Benefit Corporation Announces Oversubscribed Series A Financing and Renames to Lykos Therapeutics
MAPS Public Benefit Corp (“MAPS PBC”), a company dedicated to transforming mental healthcare, announced an oversubscribed Series A financing. MAPS PBC raised more than $100 million including conversion of previously issued convertible notes.
January 5, 2024
·
7 min read
Job Trends
BioSpace
Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
BioSpace
has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
January 20, 2026
·
2 min read
·
Chantal Dresner
Press Releases
ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk
December 10, 2025
·
10 min read
Press Releases
AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function
December 12, 2025
·
7 min read
Press Releases
Alzheon Announces Peer-Reviewed Publication Providing Evidence for Hippocampal Volume as Surrogate Marker for Clinical Benefit and Neurodegeneration in Early Alzheimer’s Disease
December 2, 2025
·
12 min read
1 of 47,515
Next
